Effect of exogenous conjugated estrogen on plasma gonadotropins and ovarian steroids during the menstrual cycle.
D000328:Adult; D004958:Estradiol / Q000097:blood*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000494:pharmacology*; D004970:Estrone / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006065:Gonadotropins, Pituitary / Q000097:blood*; D006801:Humans; D006908:Hydroxyprogesterones / Q000097:blood; D007018:Hypopituitarism / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood; D008598:Menstruation / Q000187:drug effects; D010053:Ovary / Q000187:drug effects*; D010060:Ovulation / Q000187:drug effects*; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011372:Progestins / Q000097:blood*; D011644:Puerperal Disorders / Q000097:blood; D011863:Radioimmunoassay; D013997:Time Factors
D004966:Estrogens, Conjugated (USP); D006065:Gonadotropins, Pituitary; D006908:Hydroxyprogesterones; D011372:Progestins; D004970:Estrone; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone